Forecast Period 
Market Size (Base Year) 
Market Size (Forecast Year)
CAGREurope Human Leukocyte Antigens (HLAs) Typing Transplant Diagnostics Services Market, By Product and Services (Instruments, Reagents and Consumables, Software and Services), Application (Diagnostics and Research), End-User (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Others), Technology (Polymerase Chain Reaction and Next-Generation Sequencing) – Industry Trends and Forecast to 2030.
Europe Human Leukocyte Antigens (HLAs) Typing Transplant Diagnostics Services Market Analysis and Size
The increasing prevalence of infectious diseases, rising public-private funding for target research activities, and an increase in the number of solid organ and stem cell transplantation procedures are the major factors driving the growth of the human leukocyte antigens (HLAs) typing transplant diagnostics services market during the forecast period. Furthermore, the increasing number of drug discovery activities, transplant procedures, and applications in tissue engineering, regenerative medicine, and oncology research contribute to the market's overall growth.
Data Bridge Market Research analyses that the human leukocyte antigens (HLAs) typing transplant diagnostics services market which is USD 30.00 million in 2022, is expected to reach USD 59.34 million by 2030, at a CAGR of 8.9% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Europe Human Leukocyte Antigens (HLAs) Typing Transplant Diagnostics Services Market Scope and Segmentation
|
Report Metric |
Details |
|
Forecast Period |
2023 to 2030 |
|
Base Year |
2022 |
|
Historic Years |
2021 (Customizable to 2015 - 2020) |
|
Quantitative Units |
Revenue in USD Million, Volumes in Units, Pricing in USD |
|
Segments Covered |
Product and Services (Instruments, Reagents and Consumables, Software and Services), Application (Diagnostics and Research), End-User (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Others), Technology (Polymerase Chain Reaction and Next-Generation Sequencing) |
|
Countries Covered |
Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe |
|
Market Players Covered |
Johnson & Johnson Private Limited (U.S.), Siemens (Germany), BD (U.S.), Thermo Fischer Scientific. Inc. (U.S.), QIAGEN (Germany), ProImmune Ltd. (U.K.), Creative Biolabs (U.S.), HistoGenetics LLC (U.S.), UCLA Health (U.S.), Medtronic (Ireland), Takara Bio Inc. (Japan), Biofortuna Limited (U.K.), Luminex Corporation (U.S.), Hologic, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), and Bio-Rad Laboratories, Inc. (U.S.) |
|
Market Opportunities |
|
Market Definition
Human leukocyte antigens (HLAs) typing is a medical procedure used to determine patient and donor compatibility for cord blood or bone marrow transplants. Human leukocyte antigens (HLAs) are proteins in the body that are tested using DNA-based molecular diagnostic procedures.
Europe Human Leukocyte Antigens (HLAs) Typing Transplant Diagnostics Services Market Dynamics
Drivers
- Increasing prevalence of infectious diseases
The increasing prevalence of infectious diseases, rising public-private funding for target research activities, and an increase in the number of solid organ and stem cell transplantation procedures are the major factors driving the growth of the human leukocyte antigens (HLAs) typing transplant diagnostics services market during the forecast period. Furthermore, the increasing number of drug discovery activities, transplant procedures, and applications in tissue engineering, regenerative medicine, and oncology research all contribute to the market's overall growth.
Opportunities
- Technological advancements
Technological advancements in HLA typing are a critical factor driving market growth. HLAs are highly polymorphic glycoproteins encoded by the major histocompatibility complex gene region (MHC). They have the biological function of presenting antigenic peptides to T lymphocytes. However, they play an important role in HSCT acceptance/rejection. Rising public-private funding for target research activities and an increase in the number of solid organ and stem cell transplantation procedures, among other factors driving the human leukocyte antigens (HLAs) typing transplant diagnostics services market. Furthermore, the increasing number of drug discovery activities and applications in tissue engineering, regenerative medicine, and oncology research will create new opportunities for the human leukocyte antigens (HLAs) typing transplant diagnostics services market between 2023 and 2030.
Restraints/Challenges
- High cost
Rising molecular testing costs will slow market growth. Furthermore, a lack of skilled medical professionals, a significant gap between the number of organ donors and organs, and a lack of a favourable reimbursement scenario in developing and underdeveloped economies will pose additional challenges to the market.
This human leukocyte antigens (HLAs) typing transplant diagnostics services market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the human leukocyte antigens (HLAs) typing transplant diagnostics services market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Europe Human Leukocyte Antigens (HLAs) Typing Transplant Diagnostics Services Market Scope
The human leukocyte antigens (HLAs) typing transplant diagnostics services market is segmented on the basis of product and services, application, end-user and technology. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product and Services
- Instruments
- Reagents and Consumables
- Software and Services
Application
- Diagnostics
- Research
End-User
- Direct Tender
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
Technology
- Polymerase Chain Reaction
- Next-Generation Sequencing
Europe Human Leukocyte Antigens (HLAs) Typing Transplant Diagnostics Services Market Regional Analysis/Insights
The human leukocyte antigens (HLAs) typing transplant diagnostics services market is analyzed and market size insights and trends are provided by country, product and services, application, end-user and technology as referenced above.
The countries covered in the human leukocyte antigens (HLAs) typing transplant diagnostics services market report are Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The human leukocyte antigens (HLAs) typing transplant diagnostics services market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for human leukocyte antigens (HLAs) typing transplant diagnostics services market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the human leukocyte antigens (HLAs) typing transplant diagnostics services market. The data is available for historic period 2011-2021.
Competitive Landscape and Human Leukocyte Antigens (HLAs) Typing Transplant Diagnostics Services Market Share Analysis
The human leukocyte antigens (HLAs) typing transplant diagnostics services market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to human leukocyte antigens (HLAs) typing transplant diagnostics services market.
Some of the major players operating in the human leukocyte antigens (HLAs) typing transplant diagnostics services market are:
- Johnson & Johnson Private Limited (U.S.)
- Siemens (Germany)
- BD (U.S.)
- Thermo Fischer Scientific. Inc. (U.S.)
- QIAGEN (Germany)
- ProImmune Ltd. (U.K.)
- Creative Biolabs (U.S.)
- HistoGenetics LLC (U.S.)
- UCLA Health (U.S.)
- Medtronic (Ireland)
- Takara Bio Inc. (Japan)
- Biofortuna Limited (U.K.)
- Luminex Corporation (U.S.)
- Hologic, Inc. (U.S.)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Bio-Rad Laboratories, Inc. (U.S.)
SKU-
